Incidence, Clinical Characteristics and Attributable Mortality of Persistent Bloodstream Infection in the Neonatal Intensive Care Unit
Authors:
Open Access
- 15 April 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (4) , e0124567
Abstract
An atypical pattern of neonatal sepsis, characterized by persistent positive blood culture despite effective antimicrobial therapy, has been correlated with adverse outcomes. However, previous studies focused only on coagulate-negative staphylococcus infection. All episodes of persistent bloodstream infection (BSI), defined as 3 or more consecutive positive blood cultures with the same bacterial species, at least two of them 48 hours apart, during a single sepsis episode, were enrolled over an 8-year period in a tertiary level neonatal intensive care unit. These cases were compared with all non-persistent BSI during the same period. We identified 81 episodes of persistent BSI (8.5% of all neonatal late-onset sepsis) in 74 infants, caused by gram-positive pathogens (n=38, 46.9%), gram-negative pathogens (n=21, 25.9%), fungus (n=20, 24.7%) and polymicrobial bacteremia (n=2, 2.5%). Persistent BSI does not differ from non-persistent BSI in most clinical characteristics and patient demographics, but tends to have a prolonged septic course, longer duration of feeding intolerance and more frequent requirement of blood transfusions. No difference was observed for death attributable to infection (9.8% vs. 6.5%), but neonates with persistent BSI had significantly higher rates of infectious complications (29.6% vs. 9.2%, P < 0.001), death from all causes (21.6% vs. 11.7%, P = 0.025), and duration of hospitalization among survivors [median (interquartile range): 80.0 (52.5-117.5) vs. 64.0 (40.0-96.0) days, P = 0.005] than those without persistent BSI. Although persistent BSI does not contribute directly to increased mortality, the associated morbidities, infectious complications and prolonged septic courses highlight the importance of aggressive treatment to optimize outcomes.Keywords
This publication has 33 references indexed in Scilit:
- The Epidemiology of Neonatal and Pediatric Candidemia in England and Wales, 2000–2009The Pediatric Infectious Disease Journal, 2013
- High Prevalence of Isolates with Reduced Glycopeptide Susceptibility in Persistent or Recurrent Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2012
- Combination therapy with an aminoglycoside for Staphylococcus aureus endocarditis and/or persistent bacteremia is associated with a decreased rate of recurrent bacteremia: a cohort studyInfection, 2011
- Persistent coagulase-negative staphylococci bacteremia in very-low-birth-weight infantsEuropean Journal of Pediatrics, 2011
- Use of rifampin in persistent coagulase negative staphylococcal bacteremia in neonatesBMC Pediatrics, 2010
- Neonatal Candidiasis: Epidemiology, Risk Factors, and Clinical JudgmentPediatrics, 2010
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care settingAmerican Journal of Infection Control, 2008
- Polymicrobial Bloodstream Infection in Pediatric PatientsThe Pediatric Infectious Disease Journal, 2008
- Persistent Bacteremia and Severe Thrombocytopenia Caused by Coagulase-NegativeStaphylococcusin a Neonatal Intensive Care UnitPediatrics, 2006
- When to Suspect Fungal Infection in Neonates: A Clinical Comparison ofCandida albicansandCandida parapsilosisFungemia With Coagulase-Negative Staphylococcal BacteremiaPediatrics, 2000